Author:
Santangelo Giusi,Lagana Antonio Simone,Giannini Andrea,Murina Filippo,Di Dio Camilla,Ruggiero Gianfilippo,Di Donato Violante,Perniola Giorgia,Fischetti Margherita,Casorelli Assunta,Clemente Francesco Francesco,Minnetti Marianna,Lombardo Francesco,Panici Pierluigi Benedetti,Muzii Ludovico,Bogani Giorgio
Abstract
Background: The role of hormonal replacement therapy in menopause is under debate. The premature closure of the Women’s Health Initiative (WHI) study in 2002 is still a source of concern among treating physicians.
Objectives: The interest in alternatives to conventional hormone therapy has significantly increased. The adoption of personalized steroid hormone galenic preparations, formulated by compounding pharmacies, has recently spread.
Methods: In June 2023, an extensive literature search was conducted by different authors to identify relevant studies in various databases (MEDLINE, Embase, Pubmed, and Cochrane).
The studies that met the inclusion and exclusion criteria were further analyzed, and relevant data were extracted and analyzed for each paper. Any discrepancies between the investigators were resolved through a consensus approach.
Outcomes: The primary outcomes observed included the clinical utility of CBHT.
This study reviewed the current evidence on the utility of compounded bioidentical hormones, concluding that improving knowledge and awareness of bioidentical hormones is necessary to consider their use in clinical practice.
Conclusion and Outlook: These formulations might provide effective options to best tailor therapies to each patient.
Subject
Obstetrics and Gynecology,Reproductive Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献